LAM Foundation Research Funding Program

LAM Foundation Research Funding Program The LAM Foundation is the largest funder of LAM research, outside of the National Institutes of Health.  The Foundation has committed over $10 million to LAM research, the majority of which has supported 102 peer-reviewed grants and translational projects.  LAM Foundation-funded scientists reported several major discoveries, including evidence that LAM is genetic, the identification of a LAM gene, and a molecular explanation for abnormal smooth muscle cell growth in LAM.  This data led to the identification of a therapy for LAM called sirolimus, or rapamycin, with clinical trial results published in the April 2011 issue of the New England Journal of Medicine (NEJM).  Several additional molecular targets have been identified, many of which are addressable with drugs that are FDA-approved for other indications. LAM Foundation research awards include Post-Doctoral Fellowships, Established Investigator Awards, and Pilot Project Awards.  The Foundation also considers proposals for clinical trials, bridge funding, and special projects.  Proposals are peer-reviewed, ranked by the Foundation’s Scientific Advisory Board and voted on by the Board of Directors.  A primary objective of the Foundation’s Research Program is to elevate LAM science to levels that are competitive for more substantial funding from federal sources. Examples of competitive LAM proposals include those that focus on ...
Source: ScanGrants feed - Category: Research Authors: Source Type: funding